| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.64e-04 | 749 | 54 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | nodal binding | 1.99e-04 | 8 | 54 | 2 | GO:0038100 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 7.25e-04 | 65 | 54 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.32e-03 | 20 | 54 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 2.37e-03 | 98 | 54 | 3 | GO:0051213 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 2.59e-03 | 28 | 54 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 3.17e-03 | 31 | 54 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 3.17e-03 | 31 | 54 | 2 | GO:0005160 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 3.38e-03 | 32 | 54 | 2 | GO:0140457 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 6.73e-06 | 2 | 54 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 6.73e-06 | 2 | 54 | 2 | GO:1900123 | |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 6.73e-06 | 2 | 54 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 2.18e-05 | 21 | 54 | 3 | GO:0032926 | |
| GeneOntologyBiologicalProcess | tube development | CDKN1A PRKD2 ADAMTS1 LPA LRP1 KDM2A LTBP3 CSMD1 SKI CUX1 NOTCH4 PTK7 SPINK5 | 5.01e-05 | 1402 | 54 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of activin receptor signaling pathway | 7.97e-05 | 32 | 54 | 3 | GO:0032925 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 8.19e-05 | 276 | 54 | 6 | GO:0007179 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 1.40e-04 | 7 | 54 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.53e-04 | 445 | 54 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 2.39e-04 | 336 | 54 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 2.39e-04 | 9 | 54 | 2 | GO:1900107 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.50e-04 | 482 | 54 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.67e-04 | 343 | 54 | 6 | GO:0071559 | |
| GeneOntologyBiologicalProcess | circulatory system development | CDKN1A LEFTY2 PRKD2 LEFTY1 ADAMTS1 LPA LRP1 KDM2A SKI NOTCH4 PTK7 SPINK5 | 2.85e-04 | 1442 | 54 | 12 | GO:0072359 |
| GeneOntologyBiologicalProcess | retrograde transport, vesicle recycling within Golgi | 2.99e-04 | 10 | 54 | 2 | GO:0000301 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.60e-05 | 656 | 53 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.69e-05 | 658 | 53 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.63e-04 | 530 | 53 | 7 | GO:0062023 | |
| MousePheno | abnormal left renal vein morphology | 1.15e-05 | 2 | 48 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 1.15e-05 | 2 | 48 | 2 | MP:0011323 | |
| MousePheno | abnormal kidney venous blood vessel morphology | 3.46e-05 | 3 | 48 | 2 | MP:0011311 | |
| MousePheno | abnormal dermal pigmentation | 6.90e-05 | 4 | 48 | 2 | MP:0009385 | |
| MousePheno | abnormal large intestine placement | 6.90e-05 | 4 | 48 | 2 | MP:0003284 | |
| MousePheno | absent heart right ventricle | 1.72e-04 | 6 | 48 | 2 | MP:0003872 | |
| Domain | EGF_CA | 4.87e-06 | 86 | 54 | 5 | PF07645 | |
| Domain | LRDF | 8.21e-06 | 2 | 54 | 2 | IPR003942 | |
| Domain | EGF_Ca-bd_CS | 8.80e-06 | 97 | 54 | 5 | IPR018097 | |
| Domain | EGF_CA | 9.73e-06 | 99 | 54 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.02e-05 | 100 | 54 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.36e-05 | 106 | 54 | 5 | IPR000152 | |
| Domain | EGF_CA | 2.68e-05 | 122 | 54 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.90e-05 | 124 | 54 | 5 | IPR001881 | |
| Domain | cEGF | 5.67e-05 | 26 | 54 | 3 | IPR026823 | |
| Domain | cEGF | 5.67e-05 | 26 | 54 | 3 | PF12662 | |
| Domain | EGF_3 | 5.80e-05 | 235 | 54 | 6 | PS50026 | |
| Domain | EGF | 5.80e-05 | 235 | 54 | 6 | SM00181 | |
| Domain | EGF-like_dom | 7.99e-05 | 249 | 54 | 6 | IPR000742 | |
| Domain | Growth_fac_rcpt_ | 8.67e-05 | 156 | 54 | 5 | IPR009030 | |
| Domain | EGF_1 | 9.11e-05 | 255 | 54 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.04e-04 | 261 | 54 | 6 | IPR013032 | |
| Domain | EGF_2 | 1.13e-04 | 265 | 54 | 6 | PS01186 | |
| Domain | TB | 1.71e-04 | 7 | 54 | 2 | PF00683 | |
| Domain | Ig_I-set | 2.18e-04 | 190 | 54 | 5 | IPR013098 | |
| Domain | I-set | 2.18e-04 | 190 | 54 | 5 | PF07679 | |
| Domain | - | 2.27e-04 | 8 | 54 | 2 | 3.90.290.10 | |
| Domain | TB | 2.92e-04 | 9 | 54 | 2 | PS51364 | |
| Domain | TB_dom | 2.92e-04 | 9 | 54 | 2 | IPR017878 | |
| Domain | EGF | 4.81e-04 | 126 | 54 | 4 | PF00008 | |
| Domain | IGc2 | 5.78e-04 | 235 | 54 | 5 | SM00408 | |
| Domain | Ig_sub2 | 5.78e-04 | 235 | 54 | 5 | IPR003598 | |
| Domain | DAG/PE-bd | 1.66e-03 | 21 | 54 | 2 | IPR020454 | |
| Domain | JmjC | 2.17e-03 | 24 | 54 | 2 | PF02373 | |
| Domain | ACR | 2.75e-03 | 27 | 54 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 2.75e-03 | 27 | 54 | 2 | IPR006586 | |
| Domain | LRRNT | 2.86e-03 | 98 | 54 | 3 | IPR000372 | |
| Domain | LRRNT | 2.86e-03 | 98 | 54 | 3 | SM00013 | |
| Domain | TGFb_propeptide | 2.96e-03 | 28 | 54 | 2 | PF00688 | |
| Domain | hEGF | 2.96e-03 | 28 | 54 | 2 | PF12661 | |
| Domain | TGF-b_N | 2.96e-03 | 28 | 54 | 2 | IPR001111 | |
| Domain | LRR_1 | 3.68e-03 | 219 | 54 | 4 | PF00560 | |
| Domain | TGF-beta-rel | 3.85e-03 | 32 | 54 | 2 | IPR015615 | |
| Domain | JMJC | 3.85e-03 | 32 | 54 | 2 | PS51184 | |
| Domain | JmjC_dom | 3.85e-03 | 32 | 54 | 2 | IPR003347 | |
| Domain | TGFb_CS | 3.85e-03 | 32 | 54 | 2 | IPR017948 | |
| Domain | JmjC | 4.09e-03 | 33 | 54 | 2 | SM00558 | |
| Domain | TGFB | 5.12e-03 | 37 | 54 | 2 | SM00204 | |
| Domain | TGF-b_C | 5.12e-03 | 37 | 54 | 2 | IPR001839 | |
| Domain | TGF_BETA_2 | 5.12e-03 | 37 | 54 | 2 | PS51362 | |
| Domain | TGF_beta | 5.12e-03 | 37 | 54 | 2 | PF00019 | |
| Domain | TGF_BETA_1 | 5.12e-03 | 37 | 54 | 2 | PS00250 | |
| Domain | Peptidase_M12B_N | 5.68e-03 | 39 | 54 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 5.68e-03 | 39 | 54 | 2 | PF01562 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.88e-07 | 59 | 38 | 5 | M39886 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.39e-05 | 55 | 38 | 4 | M39351 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.27e-05 | 77 | 38 | 4 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.15e-04 | 94 | 38 | 4 | M1041 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.43e-04 | 38 | 38 | 3 | MM14874 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.70e-04 | 47 | 38 | 3 | M646 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.76e-04 | 118 | 38 | 4 | MM15588 | |
| Pathway | WP_MIR127_IN_MESENDODERM_DIFFERENTIATION | 4.59e-04 | 12 | 38 | 2 | MM15910 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_NODAL | 4.59e-04 | 12 | 38 | 2 | M26952 | |
| Pathway | REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10 | 5.42e-04 | 13 | 38 | 2 | M957 | |
| Pubmed | Cell cycle arrest in node cells governs ciliogenesis at the node to break left-right symmetry. | 1.87e-06 | 15 | 57 | 3 | 21831921 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 32745796 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20056823 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 10053005 | ||
| Pubmed | Mutation analysis of human LEFTY A and LEFTY B genes in children with Ivemark syndrome. | 2.64e-06 | 2 | 57 | 2 | 11100524 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 7798248 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 24147624 | ||
| Pubmed | Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. | 2.64e-06 | 2 | 57 | 2 | 20171171 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 9496783 | ||
| Pubmed | A functional role of LEFTY during progesterone therapy for endometrial carcinoma. | 2.64e-06 | 2 | 57 | 2 | 29268772 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 9153233 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 9602168 | ||
| Pubmed | Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways. | 2.64e-06 | 2 | 57 | 2 | 33409963 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 29230527 | ||
| Pubmed | Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. | 2.64e-06 | 2 | 57 | 2 | 17038673 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 29286065 | ||
| Pubmed | Isolation, characterization, and function of EBAF/LEFTY B: role in infertility. | 2.64e-06 | 2 | 57 | 2 | 21401636 | |
| Pubmed | Lefty is expressed in mouse endometrium in estrous cycle and peri-implantation period. | 2.64e-06 | 2 | 57 | 2 | 15640253 | |
| Pubmed | ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination. | 2.79e-06 | 17 | 57 | 3 | 26581405 | |
| Pubmed | 5.27e-06 | 591 | 57 | 8 | 15231748 | ||
| Pubmed | 7.22e-06 | 75 | 57 | 4 | 20637190 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25845235 | ||
| Pubmed | Nodal and lefty signaling regulates the growth of pancreatic cells. | 7.91e-06 | 3 | 57 | 2 | 18393305 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 32065356 | ||
| Pubmed | Role of asymmetric signals in left-right patterning in the mouse. | 7.91e-06 | 3 | 57 | 2 | 11471154 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16141390 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25722189 | ||
| Pubmed | Distinct transcriptional regulation and phylogenetic divergence of human LEFTY genes. | 7.91e-06 | 3 | 57 | 2 | 10886363 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 37097539 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 22901541 | ||
| Pubmed | Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells. | 7.91e-06 | 3 | 57 | 2 | 26316705 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 20554965 | ||
| Pubmed | Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis. | 7.91e-06 | 3 | 57 | 2 | 28862766 | |
| Pubmed | TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. | 7.91e-06 | 3 | 57 | 2 | 20161788 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17011489 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17592292 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 27655833 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 21700711 | ||
| Pubmed | p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis. | 7.91e-06 | 3 | 57 | 2 | 25608711 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 9889116 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15062104 | ||
| Pubmed | Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway. | 7.91e-06 | 3 | 57 | 2 | 36017858 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 33111989 | ||
| Pubmed | Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction. | 7.91e-06 | 3 | 57 | 2 | 26647776 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 24704359 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 9865700 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25672326 | ||
| Pubmed | Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. | 7.91e-06 | 3 | 57 | 2 | 12154125 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 10743502 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 15454269 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 23028469 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 15611103 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 23544137 | ||
| Pubmed | Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis. | 1.58e-05 | 4 | 57 | 2 | 37335131 | |
| Pubmed | Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. | 1.58e-05 | 4 | 57 | 2 | 32779876 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.58e-05 | 4 | 57 | 2 | 11104663 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 19609363 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 17662710 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 9376323 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 23592333 | ||
| Pubmed | Latent TGFβ-binding proteins regulate UCP1 expression and function via TGFβ2. | 1.58e-05 | 4 | 57 | 2 | 34481123 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 9348041 | ||
| Pubmed | The role of the brachyury gene in heart development and left-right specification in the mouse. | 1.58e-05 | 4 | 57 | 2 | 10349618 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 9990851 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 27606670 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 9708732 | ||
| Pubmed | lefty-1 is required for left-right determination as a regulator of lefty-2 and nodal. | 1.58e-05 | 4 | 57 | 2 | 9708731 | |
| Pubmed | Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). | 1.58e-05 | 4 | 57 | 2 | 8084607 | |
| Pubmed | Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. | 1.58e-05 | 4 | 57 | 2 | 8610011 | |
| Pubmed | Calaxin is required for cilia-driven determination of vertebrate laterality. | 1.58e-05 | 4 | 57 | 2 | 31240264 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 11448943 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.29e-05 | 1201 | 57 | 10 | 35696571 | |
| Pubmed | Foxj1 regulates asymmetric gene expression during left-right axis patterning in mice. | 2.63e-05 | 5 | 57 | 2 | 15504371 | |
| Pubmed | Identification of Four Mouse Diabetes Candidate Genes Altering β-Cell Proliferation. | 2.63e-05 | 5 | 57 | 2 | 26348837 | |
| Pubmed | Nodal signaling induces the midline barrier by activating Nodal expression in the lateral plate. | 2.63e-05 | 5 | 57 | 2 | 12642485 | |
| Pubmed | Diffusion of nodal signaling activity in the absence of the feedback inhibitor Lefty2. | 2.63e-05 | 5 | 57 | 2 | 11703930 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 15308665 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 10677256 | ||
| Pubmed | Regulation of left-right patterning in mice by growth/differentiation factor-1. | 2.63e-05 | 5 | 57 | 2 | 10700179 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 15750185 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 21266536 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 17075880 | ||
| Pubmed | Nodal signaling regulates the entry into meiosis in fetal germ cells. | 2.63e-05 | 5 | 57 | 2 | 22396454 | |
| Pubmed | Lineage-specific functions of TET1 in the postimplantation mouse embryo. | 2.63e-05 | 5 | 57 | 2 | 28504700 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 18628488 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 10385627 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 10500184 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 19147818 | ||
| Pubmed | A role of the cryptic gene in the correct establishment of the left-right axis. | 3.94e-05 | 6 | 57 | 2 | 10574770 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 10678167 | ||
| Pubmed | Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH. | 3.94e-05 | 6 | 57 | 2 | 10411502 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 10603343 | ||
| Pubmed | Nodal antagonists regulate formation of the anteroposterior axis of the mouse embryo. | 3.94e-05 | 6 | 57 | 2 | 15004567 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 21364967 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 32579954 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 18039650 | ||
| Pubmed | Mapping of human and murine genes for latent TGF-beta binding protein-2 (LTBP2). | 3.94e-05 | 6 | 57 | 2 | 7719025 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 24379373 | ||
| Pubmed | The mouse embryo autonomously acquires anterior-posterior polarity at implantation. | 5.51e-05 | 7 | 57 | 2 | 16580991 | |
| Interaction | TRIM40 interactions | 5.70e-06 | 13 | 56 | 3 | int:TRIM40 | |
| Interaction | ZNF628 interactions | 1.11e-05 | 16 | 56 | 3 | int:ZNF628 | |
| Cytoband | 1q42.1 | 9.92e-05 | 12 | 57 | 2 | 1q42.1 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.02e-05 | 161 | 33 | 5 | 593 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.93e-05 | 4 | 33 | 2 | 628 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 9.70e-07 | 355 | 57 | 8 | M45758 | |
| Coexpression | NABA_MATRISOME | LEFTY2 LEFTY1 P4HTM HMCN1 ADAMTS1 LPA LTBP2 LTBP3 VWA7 ADAM22 BGN | 9.39e-06 | 1008 | 57 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | LEFTY2 LEFTY1 P4HTM HMCN1 ADAMTS1 LPA LTBP2 LTBP3 VWA7 ADAM22 BGN | 1.11e-05 | 1026 | 57 | 11 | M5889 |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 6.01e-05 | 313 | 57 | 6 | M39128 | |
| Coexpression | GHANDHI_DIRECT_IRRADIATION_DN | 6.07e-05 | 35 | 57 | 3 | M2594 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 6.31e-05 | 193 | 57 | 5 | M39321 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 6.93e-05 | 6 | 57 | 2 | M1764 | |
| Coexpression | TESAR_ALK_TARGETS_HUMAN_ES_4D_DN | 6.93e-05 | 6 | 57 | 2 | M16516 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 7.03e-05 | 322 | 57 | 6 | MM3786 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 8.39e-05 | 205 | 57 | 5 | M39302 | |
| Coexpression | TESAR_ALK_TARGETS_HUMAN_ES_5D_DN | 9.69e-05 | 7 | 57 | 2 | M2811 | |
| Coexpression | HOELZEL_NF1_TARGETS_DN | 1.28e-04 | 118 | 57 | 4 | M2143 | |
| Coexpression | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP | 1.66e-04 | 9 | 57 | 2 | M18679 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.78e-04 | 50 | 57 | 3 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.00e-04 | 52 | 57 | 3 | MM1118 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 2.07e-04 | 10 | 57 | 2 | MM741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-09 | 187 | 56 | 7 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-09 | 187 | 56 | 7 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.95e-09 | 200 | 56 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-07 | 187 | 56 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.30e-07 | 187 | 56 | 6 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-07 | 192 | 56 | 6 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.61e-07 | 194 | 56 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-07 | 195 | 56 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-07 | 197 | 56 | 6 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-07 | 197 | 56 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.88e-07 | 199 | 56 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-07 | 199 | 56 | 6 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.88e-07 | 199 | 56 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-07 | 199 | 56 | 6 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.93e-07 | 200 | 56 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-07 | 200 | 56 | 6 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.46e-06 | 154 | 56 | 5 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-06 | 171 | 56 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.73e-06 | 175 | 56 | 5 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 176 | 56 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 176 | 56 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-06 | 177 | 56 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-06 | 177 | 56 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-06 | 181 | 56 | 5 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 182 | 56 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 182 | 56 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 3.40e-06 | 183 | 56 | 5 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 185 | 56 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 186 | 56 | 5 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-06 | 186 | 56 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 186 | 56 | 5 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.88e-06 | 188 | 56 | 5 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.88e-06 | 188 | 56 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-06 | 189 | 56 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 189 | 56 | 5 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 189 | 56 | 5 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.98e-06 | 189 | 56 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-06 | 189 | 56 | 5 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.09e-06 | 190 | 56 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 190 | 56 | 5 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-06 | 190 | 56 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 191 | 56 | 5 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.19e-06 | 191 | 56 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 191 | 56 | 5 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-06 | 191 | 56 | 5 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.19e-06 | 191 | 56 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-06 | 191 | 56 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.19e-06 | 191 | 56 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 191 | 56 | 5 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.30e-06 | 192 | 56 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 192 | 56 | 5 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-06 | 193 | 56 | 5 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-06 | 193 | 56 | 5 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.41e-06 | 193 | 56 | 5 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-06 | 194 | 56 | 5 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.52e-06 | 194 | 56 | 5 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-06 | 194 | 56 | 5 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.52e-06 | 194 | 56 | 5 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-06 | 194 | 56 | 5 | 6e12a7da35be4c0ecf998ef94b8989b89d74b200 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.52e-06 | 194 | 56 | 5 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.52e-06 | 194 | 56 | 5 | 3c661c6768c3f05d2aba03d329adb257ca201b2d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-06 | 194 | 56 | 5 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-06 | 194 | 56 | 5 | c52f10140c66e8c0566421c3d535d5d92bf595e1 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 4.64e-06 | 195 | 56 | 5 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.64e-06 | 195 | 56 | 5 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-06 | 195 | 56 | 5 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-06 | 195 | 56 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-06 | 195 | 56 | 5 | a3b468125e48f072255cede7645f6692298ecf54 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-06 | 196 | 56 | 5 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.75e-06 | 196 | 56 | 5 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.75e-06 | 196 | 56 | 5 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 196 | 56 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-06 | 196 | 56 | 5 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 196 | 56 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.75e-06 | 196 | 56 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 197 | 56 | 5 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-06 | 197 | 56 | 5 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-06 | 197 | 56 | 5 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.87e-06 | 197 | 56 | 5 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-06 | 197 | 56 | 5 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.00e-06 | 198 | 56 | 5 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 198 | 56 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.00e-06 | 198 | 56 | 5 | c7075dce915ab8387309fcb12c5f6a17d4100cda | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.00e-06 | 198 | 56 | 5 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.00e-06 | 198 | 56 | 5 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 5.00e-06 | 198 | 56 | 5 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 198 | 56 | 5 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.12e-06 | 199 | 56 | 5 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.12e-06 | 199 | 56 | 5 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.12e-06 | 199 | 56 | 5 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.12e-06 | 199 | 56 | 5 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.12e-06 | 199 | 56 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-06 | 199 | 56 | 5 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 199 | 56 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-06 | 199 | 56 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-06 | 199 | 56 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 5.12e-06 | 199 | 56 | 5 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.12e-06 | 199 | 56 | 5 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| Computational | ECM and collagens. | 7.68e-05 | 225 | 35 | 6 | MODULE_47 | |
| Disease | cholesteryl ester 16:2 measurement | 6.86e-05 | 7 | 54 | 2 | EFO_0021435 | |
| Disease | JT interval | 9.10e-05 | 248 | 54 | 5 | EFO_0007885 | |
| Disease | melanoma (implicated_via_orthology) | 9.14e-05 | 8 | 54 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | aortic measurement | 9.63e-05 | 251 | 54 | 5 | EFO_0020865 | |
| Disease | QRS duration | 2.14e-04 | 298 | 54 | 5 | EFO_0005055 | |
| Disease | Mitral valve prolapse, response to surgery | 2.14e-04 | 12 | 54 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 2.14e-04 | 12 | 54 | 2 | EFO_0010822 | |
| Disease | Carcinogenesis | 2.53e-04 | 13 | 54 | 2 | C0596263 | |
| Disease | Abdominal Aortic Aneurysm | 2.67e-04 | 68 | 54 | 3 | EFO_0004214 | |
| Disease | ankle brachial index | 3.88e-04 | 16 | 54 | 2 | EFO_0003912 | |
| Disease | saturated fatty acids to total fatty acids percentage | 6.75e-04 | 21 | 54 | 2 | EFO_0022305 | |
| Disease | Adenocarcinoma of large intestine | 7.34e-04 | 96 | 54 | 3 | C1319315 | |
| Disease | anxiety | 7.47e-04 | 223 | 54 | 4 | EFO_0005230 | |
| Disease | airway responsiveness measurement | 8.84e-04 | 24 | 54 | 2 | EFO_0006897 | |
| Disease | suicidal ideation | 1.29e-03 | 29 | 54 | 2 | EFO_0004320 | |
| Disease | glutamate measurement | 1.29e-03 | 29 | 54 | 2 | EFO_0010487 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.34e-03 | 447 | 54 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | Neural Tube Defects | 1.38e-03 | 30 | 54 | 2 | C0027794 | |
| Disease | uridine measurement | 1.57e-03 | 32 | 54 | 2 | EFO_0010546 | |
| Disease | FEV/FEC ratio | 1.67e-03 | 1228 | 54 | 8 | EFO_0004713 | |
| Disease | lupus nephritis | 1.67e-03 | 33 | 54 | 2 | EFO_0005761 | |
| Disease | Malignant Neoplasms | 1.68e-03 | 128 | 54 | 3 | C0006826 | |
| Disease | vital capacity | 1.74e-03 | 1236 | 54 | 8 | EFO_0004312 | |
| Disease | longevity | 1.82e-03 | 284 | 54 | 4 | EFO_0004300 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVGPEDAGACSGRNP | 1 | O60347 | |
| MSSPQAPEDGQGCGD | 1 | O14734 | |
| GAEPGQALFNGDMEP | 11 | P15056 | |
| MSEPAGDVRQNPCGS | 1 | P38936 | |
| CNDPGMPQNGTRYGD | 1391 | Q96PZ7 | |
| APGLDPQGAADCAQG | 791 | P39880 | |
| PPARCGQAGDASLME | 21 | Q9P0K1 | |
| GERAFDGMEPLCQPG | 26 | Q96MT4 | |
| PLQACENLAMNEGGP | 191 | Q8IZT6 | |
| PPDHCQAQAAAGLGD | 26 | Q9NXG6 | |
| GEQMCPGAACQAPPD | 381 | Q86UN3 | |
| DNGHGECLMDKPQNP | 456 | Q9UHI8 | |
| NEAGPMEEARPCGAG | 151 | Q6ZSG2 | |
| HGRNSMAPPCGDMEN | 271 | Q8IWB1 | |
| CTGDANGHLQEEPPM | 541 | Q9NPH2 | |
| APVPAEDGGSDAGMC | 551 | Q96RG2 | |
| GAQGDCDPEAPMTEG | 246 | O75610 | |
| SLGMGPCHGPEENEY | 446 | Q7Z434 | |
| DPIQGPDGKMHGNTC | 456 | Q9NQ38 | |
| SRQPMAPNPCEANGG | 1531 | Q07954 | |
| RDGEMGAGRQQNPCP | 251 | O43593 | |
| TGMQEDPGNPAGGCS | 791 | Q5SYE7 | |
| PCPDQGCPQMGHYAD | 316 | P54315 | |
| NCIEMGGNPLENSGF | 186 | P21810 | |
| DQLPCDDPMAGSGGA | 111 | Q13670 | |
| DLGGACPPQDHDMQG | 856 | Q9BZL6 | |
| CEMVQPSGGPAADQD | 11 | Q9Y6K9 | |
| GGQQPMCAGPDTIRE | 376 | Q7L985 | |
| PANGGKPCQGSDLEM | 4561 | Q96RW7 | |
| MCADNRNGECPMHGP | 201 | Q9NQX0 | |
| AADDINPAPANMEGG | 21 | Q9UP83 | |
| NEIVHPGCLQMDGEG | 646 | Q9Y2K7 | |
| LANGARGFCPEMGQN | 146 | Q6ZV77 | |
| DVNDPMPNRGGNGLA | 46 | Q86SF2 | |
| SLGPPSEQDCMFGNG | 1711 | P08519 | |
| GAQGDCDPEAPMTEG | 246 | O00292 | |
| VLGCQPGFHMAPNGD | 1286 | Q14767 | |
| PGFHMAPNGDCIDID | 1291 | Q14767 | |
| MPGVCRHGDCLNNPG | 361 | Q9NS15 | |
| ARAPQDPGGMAQACE | 506 | O75426 | |
| ALDEPQLCNGHMGGA | 1241 | O75064 | |
| PPQGPMEVQDCHRAG | 646 | Q86VF2 | |
| LAGAMPNEAGGHPDA | 466 | Q9Y613 | |
| CLMAQQGPSPCEHGG | 436 | Q99466 | |
| MEAAAGGRGCFQPHP | 1 | P12755 | |
| PGDETQHMGCVFCDP | 791 | O95985 | |
| QPMAPHCPAGRADGA | 306 | Q9BU70 | |
| QACGGDMPALEGAPH | 76 | Q9H0X6 | |
| MPDNGAVHNDRFPQG | 456 | Q8WXF1 | |
| MSCGENHGVRPPNPE | 251 | Q9NX95 | |
| PGCMCQGVFNPNSED | 736 | O75038 | |
| HLGALACQDPPGRQM | 986 | O94964 | |
| SCIMENGHQPGAGPG | 151 | Q2TAL5 | |
| NEIHALGGGDEPEMC | 381 | Q9Y334 | |
| GEEPEMECLNGGPLQ | 741 | Q13308 | |
| LKPDMPNGSGRNNDC | 341 | O95405 | |
| MRQGHAPEESEPGCE | 1 | Q6PF15 | |
| GAPGAPMDLQCHDAN | 381 | P54296 | |
| PSPMGGDSNRCLQEE | 991 | Q5VU43 |